Genzyme Corp, one of the largest biotech companies, has succeeded in developing, manufacturing, and commercialization of its first therapeutic for the treatment of rare genetic diseases. Analysis of the case requires students to identify and understand how Genzyme has developed its strategy to effectively manage, mitigate, or use the uncertainty it faced in the past. In 1993, the company faces challenges in the management of future uncertainty with the market of the product, production and pricing. "Hide
by Elizabeth Olmsted Teisberg, Sharon Rossi Source: Harvard Business School 25 pages. Publication Date: Apr 09, 1993. Prod. #: 793120-PDF-ENG
Related Case Solutions & Analyses:
Mattel: Crisis Management or Management Crisis
Erika James: The Life and Career of an Associate Professor
Communicating Corporate Reputation Through Stories
Basil Buzz Hargrove and de Havilland Inc. Video
Camp Dresser & McKee: Getting Incentives Right
Interview with Philip Casey at AmeriSteel Video
Running and Growing the Small Company Course Overview
Mercer Management Consultings Grow to Be Great (A): The Growth Initiative
Japanese Leadership: The Case of Testsundo Iwakuni
Jupiter Management Co.
